1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,820 | 0,832 | 07:57 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Bioretec Oy Q3 Loss Widens | 1 | RTTNews | ||
| Do | Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design | 434 | PR Newswire | Bioretec Ltd Company release 13 November 2025 at 8.30 a.m. EET
TAMPERE, Finland, Nov. 13, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for... ► Artikel lesen | |
| Mi | Inside information: Bioretec initiates change negotiations to enhance operational efficiency and competitiveness | 220 | PR Newswire | Bioretec Ltd Inside information 12 November 2025 at 12.30 p.m. EET
TAMPERE, Finland, Nov. 12, 2025 /PRNewswire/ -- Bioretec Ltd is initiating change negotiations in accordance... ► Artikel lesen | |
| 31.10. | Bioretec Ltd.: Half-year report 2025 - Correction | 427 | PR Newswire | Bioretec Ltd Company release 31 October 2025 at 8.30 a.m. EET
TAMPERE, Finland, Oct. 31, 2025 /PRNewswire/ -- Bioretec announced on 27 October 2025 that it will adjust and restate... ► Artikel lesen | |
| 27.10. | Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025 | 265 | PR Newswire | Bioretec Ltd Inside information 27 October 2025 at 9.14 p.m. EEST
TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company")... ► Artikel lesen | |
| 27.10. | Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets | 249 | PR Newswire | Bioretec Ltd Inside information 26 October 2025 at 10.00 a.m. EEST
TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 12 September 2025, Bioretec Ltd ("Bioretec" or the "Company")... ► Artikel lesen | |
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 01.10. | Bioretec's RemeOs Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US | 202 | PR Newswire | TAMPERE, Finland, Oct. 1, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted... ► Artikel lesen | |
| 16.09. | Composition of Bioretec's Shareholders' Nomination Board | 3 | Cision News | ||
| 15.09. | Bioretec Oy: Inside information: Anne-Mari Matikainen appointed as Interim Chief Financial Officer of Bioretec; CFO Johanna Salko to depart before year-end | 134 | GlobeNewswire (Europe) | Bioretec Ltd Inside information 15 September 2025 at 5.30 p.m. EEST
Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Anne-Mari Matikainen as Interim Chief Financial Officer, effective... ► Artikel lesen | |
| 15.09. | New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register | 1 | Cision News | ||
| 15.09. | Bioretec Oy: Shares Subscribed With Option Rights | 160 | GlobeNewswire | NOTICE, SEPTEMBER 15, 2025 SHARES (Record Id 315934) A total of 5,000 shares will be traded as old shares as of September 16, 2025 on First North Growth Market Finland.
Identifiers of Bioretec Oy's... ► Artikel lesen | |
| 12.09. | Bioretec Oy: Inside information: Bioretec updates the commercialization status of RemeOs DrillPin | 264 | GlobeNewswire (Europe) | Bioretec Ltd Inside information 12 September 2025 at 11:00 a.m. EEST
Bioretec Ltd., a pioneer in absorbable orthopedic implants, announces an update to the commercialization status of the RemeOs DrillPin.... ► Artikel lesen | |
| 04.09. | Bioretec adds Harvard orthopedic surgeon to scientific board | 2 | Investing.com | ||
| 04.09. | Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board | 222 | PR Newswire | Bioretec Ltd Press Release 4 September 2025 at 3 p.m. EET
TAMPERE, Finland, Sept. 4, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced... ► Artikel lesen | |
| 02.09. | Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth | 623 | PR Newswire | TAMPERE, Finland, Sept. 2, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters
as Vice President of Sales... ► Artikel lesen | |
| 28.08. | Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH) | 3 | Cision News | ||
| 27.08. | Bioretec selects its next CEO | 2 | MassDevice | ||
| 27.08. | Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer | 308 | PR Newswire | TAMPERE, Finland, Aug. 27, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, announced today the appointment of Sarah van Hellenberg Hubar-Fisher as Chief Executive... ► Artikel lesen | |
| 14.08. | Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue | 379 | PR Newswire | TAMPERE, Finland, Aug. 14, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 14 August 2025 at 8.00 am EEST
This company announcement is a summary of Bioretec Ltd's half-year report... ► Artikel lesen | |
| 11.07. | René Eve appointed as Director of Operations of Bioretec Ltd. | 2 | Cision News |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,090 | -1,11 % | DAX-Check LIVE: Bilfinger, Cancom, Telekom, Eckert & Ziegler, Friedrich Vorwerk, Merck, SMA, Talanx | Die Aussicht auf ein Ende des US-Shutdowns und starke Unternehmenszahlen aus dem DAX haben den deutschen Aktienmarkt zur Wochenmitte deutlich beflügelt. Der DAX legte 1,22 Prozent auf 24.381 Punkte... ► Artikel lesen | |
| DRAEGERWERK | 68,30 | -0,73 % | Dreifach-Chance bei Drägerwerk | Die Aktien von Drägerwerk handeln weit unter dem, was möglich wäre. Ein einfacher Vergleich macht das offensichtlich. Der Börsenwert der Stamm- und Vorzugsaktien beträgt zusammen nicht ganz 1,2 Milliarden.... ► Artikel lesen | |
| INTUITIVE SURGICAL | 472,55 | +0,18 % | Intuitive Surgical Stock Is Up 31% Since October Lows After Powerful Earnings Turnaround | ||
| INSULET | 288,80 | +2,05 % | The Wild Ride That Sent IBD Stock Of The Day Insulet Into An Early Breakout | ||
| CYTOSORBENTS | 0,611 | +7,95 % | Cytosorbents Corp: CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update | Third quarter 2025 revenue of $9.5 million, up 10% year-over-year
Amended credit agreement with Avenue Capital Group which strengthens our balance sheet... ► Artikel lesen | |
| GENEDX | 129,48 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| REVENIO GROUP | 22,750 | 0,00 % | Revenio Group Corporation: Interim report January 1- September 30, 2025 | Revenio Group Corporation | Stock Exchange Release | October 30, 2025 at 09:00:00 EET
Another quarter of profitable growthThis release is a summary of Revenio's Interim report for January 1- September... ► Artikel lesen | |
| OPTOMED | 4,050 | -0,25 % | Optomed Oyj: Interim Report, January - September 2025 | Optomed PlcStock Exchange Release 6 November 2025 at 9.00, Helsinki
Optomed Plc: Interim Report, January - September 2025July- September 2025
Revenue increased by 42.1 percent to EUR 4.4 (3.1) million.
Currency-adjusted... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,780 | -4,76 % | Entscheidung zu Healthineers: Siemens-Aktionäre erleben Woche der Wahrheit | Gespannt erwartet die Börse die Entscheidung des Technologiekonzerns Siemens über seine Tochter Healthineers. Am Donnerstag (13.11.) lädt der Technologiekonzern zum Kapitalmarkttag - und legt Zahlen... ► Artikel lesen | |
| FRESENIUS | 48,850 | +0,27 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 57 Euro auf "Buy" belassen. Das operative Ergebnis (Ebit) habe von besseren Unternehmenskosten... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,090 | -0,89 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 31,360 | -2,06 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GERRESHEIMER | 24,340 | -1,46 % | Beiersdorf, Continental, Deutsche Pfandbriefbank, Gerresheimer, K+S, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,040 | -2,91 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,400 | -3,00 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen |
Das Unternehmen BIORETEC OY kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,832 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.